Organization | Palo Alto Veterans Institute for Research

Palo Alto Veterans Institute for Research Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Palo Alto CA United States (1988)

Organization Overview

First Clinical Trial

2003

NCT00282958

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2024

Timeline

NOW

Now

Alternative names

Palo Alto Veterans Institute for Research | Ronald L. Dalman, MD

Active Ingredients

Drugs in Phase 4 Trials (2)

clonazepam (klonopin) (1 trial)

telmisartan (micardis) (1 trial)

Drugs in Phase 3 Trials (4)

lithium (lithonate) (1 trial)

memantine (namenda) (1 trial)

quetiapine (seroquel) (1 trial)

valproic acid (depakene) (1 trial)

Drugs in Phase 2 Trials (2)

3,4-Methylenedioxymethamphetamine (1 trial)

formoterol (foradil) (1 trial)

Drugs in Phase 1 Trials (1)

oxytocin (syntocinon) (1 trial)

Drugs in Other Trials (1)

rimabotulinumtoxinB (Myobloc) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Alzheimer Disease (Phase 3)

Aneurysm (Phase 4)

Aortic Aneurysm (Phase 4)

Aortic Aneurysm, Abdominal (Phase 4)

Bipolar Disorder (Phase 3)

Cognitive Dysfunction (Phase 2)

Disease (Phase 4)

Psychotic Disorders (Phase 4)

Schizophrenia (Phase 4)

Stress Disorders, Post-Traumatic (Phase 1)

Overview

Highest Phase: Phase 4
# of Trials: 8
# of Trial APIs: 10